Is Zura Bio Stock a Good Investment?
Zura Bio Investment Advice | ZURA |
- Examine Zura Bio's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Zura Bio's leadership team and their track record. Good management can help Zura Bio navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Zura Bio's business and its evolving consumer preferences.
- Compare Zura Bio's performance and market position to its competitors. Analyze how Zura Bio is positioned in terms of product offerings, innovation, and market share.
- Check if Zura Bio pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Zura Bio's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Zura Bio Limited stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Zura Bio Limited is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Moderately volatile | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Zura Bio Stock
Researching Zura Bio's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 32.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 1.24. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Zura Bio Limited had not issued any dividends in recent years.
To determine if Zura Bio is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Zura Bio's research are outlined below:
| Zura Bio Limited generated a negative expected return over the last 90 days | |
| Zura Bio Limited has high historical volatility and very poor performance | |
| Net Loss for the year was (60.56 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Zura Bio generates negative cash flow from operations | |
| Zura Bio Limited has a poor financial position based on the latest SEC disclosures | |
| About 32.0% of the company outstanding shares are owned by insiders | |
| Latest headline from thelincolnianonline.com: HC Wainwright Reaffirms Neutral Rating for Zura Bio |
Zura Bio Quarterly Cash And Short Term Investments |
|
Zura Bio uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Zura Bio Limited. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Zura Bio's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 26th of March 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Zura Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Zura Bio's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-13 | 2024-06-30 | -0.15 | -0.17 | -0.02 | 13 | ||
2024-03-28 | 2023-12-31 | -0.23 | -0.19 | 0.04 | 17 | ||
2023-11-13 | 2023-09-30 | -0.25 | -0.18 | 0.07 | 28 | ||
2024-11-07 | 2024-09-30 | -0.12 | -0.26 | -0.14 | 116 | ||
2024-05-09 | 2024-03-31 | -0.23 | -0.02 | 0.21 | 91 | ||
2023-08-14 | 2023-06-30 | -0.25 | -1.31 | -1.06 | 424 |
Zura Bio's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 295.78 M.Market Cap |
|
Zura Bio's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.60) | (0.57) | |
| Return On Capital Employed | (0.78) | (0.74) | |
| Return On Assets | (0.60) | (0.57) | |
| Return On Equity | (1.02) | (0.97) |
Determining Zura Bio's profitability involves analyzing its financial statements and using various financial metrics to determine if Zura Bio is a good buy. For example, gross profit margin measures Zura Bio's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Zura Bio's profitability and make more informed investment decisions.
Please note, the presentation of Zura Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Zura Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Zura Bio's management manipulating its earnings.
Evaluate Zura Bio's management efficiency
Zura Bio Limited has return on total asset (ROA) of (0.214) % which means that it has lost $0.214 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3685) %, meaning that it created substantial loss on money invested by shareholders. Zura Bio's management efficiency ratios could be used to measure how well Zura Bio manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.57. The current year's Return On Capital Employed is expected to grow to -0.74. At present, Zura Bio's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 105.9 M, whereas Total Assets are forecasted to decline to about 90.6 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.41 | 2.67 | |
| Tangible Book Value Per Share | 2.41 | 2.67 | |
| Enterprise Value Over EBITDA | (0.73) | (0.69) | |
| Price Book Value Ratio | 2.42 | 2.30 | |
| Enterprise Value Multiple | (0.73) | (0.69) | |
| Price Fair Value | 2.42 | 2.30 | |
| Enterprise Value | 39.6 M | 35.2 M |
The strategic initiatives led by Zura Bio's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Beta 0.135 |
Basic technical analysis of Zura Stock
As of the 22nd of November, Zura Bio maintains the Market Risk Adjusted Performance of (0.08), mean deviation of 3.78, and Standard Deviation of 5.02. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Zura Bio Limited, as well as the relationship between them.Zura Bio's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zura Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zura Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Zura Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Zura Bio's Outstanding Corporate Bonds
Zura Bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Zura Bio Limited uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Zura bonds can be classified according to their maturity, which is the date when Zura Bio Limited has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Understand Zura Bio's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Zura Bio's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.08) | |||
| Mean Deviation | 3.78 | |||
| Coefficient Of Variation | (2,804) | |||
| Standard Deviation | 5.02 | |||
| Variance | 25.2 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (0.76) | |||
| Treynor Ratio | (0.09) | |||
| Maximum Drawdown | 30.69 | |||
| Value At Risk | (7.94) | |||
| Potential Upside | 7.95 | |||
| Skewness | (0.46) | |||
| Kurtosis | 1.79 |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.08) | |||
| Mean Deviation | 3.78 | |||
| Coefficient Of Variation | (2,804) | |||
| Standard Deviation | 5.02 | |||
| Variance | 25.2 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (0.76) | |||
| Treynor Ratio | (0.09) | |||
| Maximum Drawdown | 30.69 | |||
| Value At Risk | (7.94) | |||
| Potential Upside | 7.95 | |||
| Skewness | (0.46) | |||
| Kurtosis | 1.79 |
Consider Zura Bio's intraday indicators
Zura Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Zura Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 7210.05 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 2.95 | |||
| Day Typical Price | 2.94 | |||
| Price Action Indicator | (0.03) | |||
| Relative Strength Index | 34.26 |
Zura Bio Corporate Filings
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 7th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 16th of September 2024 Other Reports | ViewVerify | |
F4 | 13th of September 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Zura Stock media impact
Far too much social signal, news, headlines, and media speculation about Zura Bio that are available to investors today. That information is available publicly through Zura media outlets and privately through word of mouth or via Zura internal channels. However, regardless of the origin, that massive amount of Zura data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Zura Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Zura Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Zura Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Zura Bio alpha.
Zura Bio Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Zura Bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Zura Bio Corporate Management
| Gary Whale | Chief Officer | Profile | |
| David Brady | Head Development | Profile | |
| Kiran MBBS | Chief Development | Profile | |
| Kimberly Davis | Chief Secretary | Profile | |
| Theresa Lowry | Chief Officer | Profile | |
| Verender Badial | Chief Officer | Profile | |
| Michael Howell | Chief Medicine | Profile |
Already Invested in Zura Bio Limited?
The danger of trading Zura Bio Limited is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Zura Bio is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Zura Bio. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Zura Bio Limited is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Zura Bio Limited offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zura Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zura Bio Limited Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zura Bio Limited Stock: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zura Bio Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zura Bio. If investors know Zura will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zura Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.57 | Return On Assets (0.21) | Return On Equity (0.37) |
The market value of Zura Bio Limited is measured differently than its book value, which is the value of Zura that is recorded on the company's balance sheet. Investors also form their own opinion of Zura Bio's value that differs from its market value or its book value, called intrinsic value, which is Zura Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zura Bio's market value can be influenced by many factors that don't directly affect Zura Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Zura Bio's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Zura Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zura Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.